title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study",20220802T122759,https://www.benzinga.com/general/biotech/22/08/28308082/biotech-daily-trial-setback-for-eliem-therapeutics-allarity-drops-work-on-cancer-monotherapies-ax,XNCR,0.157483,Neutral,0.009685
Stocks That Hit 52-Week Lows On Thursday,20220428T193101,https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article,XNCR,0.00644,Neutral,0.008116
Stocks That Hit 52-Week Lows On Monday,20220418T154044,https://www.benzinga.com/news/22/04/26669813/stocks-that-hit-52-week-lows-on-monday,XNCR,0.005428,Neutral,0.017634
Stocks That Hit 52-Week Lows On Tuesday,20220315T163235,https://www.benzinga.com/news/22/03/26148458/stocks-that-hit-52-week-lows-on-tuesday,XNCR,0.00539,Neutral,-0.000419
Stocks That Hit 52-Week Lows On Monday,20220613T161842,https://www.benzinga.com/markets/options/22/06/27677156/52-weeks-high-and-low-article,XNCR,0.005366,Neutral,0.009636
Stocks That Hit 52-Week Lows On Thursday,20220602T172744,https://www.benzinga.com/markets/options/22/06/27526024/52-weeks-high-and-low-article,XNCR,0.053402,Neutral,0.017839
Stocks That Hit 52-Week Lows On Wednesday,20220504T162909,https://www.benzinga.com/markets/options/22/05/26995541/52-weeks-high-and-low-article,XNCR,0.012359,Neutral,0.001653
"Stocks That Hit 52-Week Lows On Wednesday - Bristol-Myers Squibb Company Common Stock  ( NYSE:BMY ) , SenesTech, Inc. - Common Stock  ( NASDAQ:SNES ) ",20231004T160117,https://www.benzinga.com/markets/options/23/10/35092508/stocks-that-hit-52-week-lows-on-wednesday,XNCR,0.012708,Neutral,0.004414
"Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period  ( 2019-2032 ) , Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo",20231004T210100,https://www.prnewswire.com/news-releases/small-cell-lung-cancer-market-to-accelerate-substantially-during-the-study-period-20192032-assesses-delveinsight--leading-companies----amgen-novartis-abbvie-bms-clovis-oncology-cardiff-oncology-roche-daiichi-sankyo-301946615.html,XNCR,0.021778,Neutral,-0.066559
Stocks That Hit 52-Week Lows On Friday,20220610T154524,https://www.benzinga.com/markets/options/22/06/27650434/52-weeks-high-and-low-article,XNCR,0.013393,Neutral,0.008469
CD3 Antibody Clinical Trials Market Opportunity Insight,20231012T062602,https://www.benzinga.com/pressreleases/23/10/g35212251/cd3-antibody-clinical-trials-market-opportunity-insight,XNCR,0.047278,Somewhat-Bullish,0.188605
Bispecific Antibody Clinical Trial Pipeline Appears Robust With 250+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight,20230703T210100,https://www.prnewswire.com/news-releases/bispecific-antibody-clinical-trial-pipeline-appears-robust-with-250-key-pharma-companies-actively-working-in-the-therapeutics-segment--delveinsight-301868673.html,XNCR,0.020404,Neutral,0.003677
Stocks That Hit 52-Week Lows On Friday,20220527T192849,https://www.benzinga.com/markets/options/22/05/27444271/52-weeks-high-and-low-article,XNCR,0.077144,Neutral,0.019047
Stocks That Hit 52-Week Lows On Wednesday,20220601T161607,https://www.benzinga.com/markets/options/22/06/27503658/52-weeks-high-and-low-article,XNCR,0.062426,Neutral,0.008059
"Earnings Scheduled For May 5, 2022",20220505T084322,https://www.benzinga.com/news/earnings/22/05/27012606/earnings-scheduled-for-may-5-2022,XNCR,0.009774,Neutral,-0.061126
